About Our Research

Anesthesiology has been undergoing major changes globally, expanding roles beyond the operating room in offering high-quality personalized services in peri-operative health, pain management, critical care, and other medical disciplines. Research has been a major factor underlining these changes and will continue to be an essential force driving the evolution of the specialty.
 
Stanford Anesthesiology research includes a wide spectrum of programs in basic, translational, clinical, health service, and medical education areas. Project fields range from subcellular mechanisms of anesthesia, pain, and opioid addiction, tissue/organ injury, novel anesthesia agents, techniques and devices, treatment effectiveness, epidemiology, patient safety, health economics, and other areas. Interdisciplinary collaborations are increasingly a feature. Our department has been among the top five NIH funded anesthesia departments since 2011 and has also been ranked #1 in the Blue Ridge rankings for 2024, with current external research grants and contracts totaling $31.2 million annually.
 

Stanford Anesthesia pays special attention to research training for the next generation of anesthesiologists and has established a research-training continuum bridging between medical student and faculty stages. We place special emphasis on supporting the residency-fellowship-junior faculty period. A key part of this support is the Fellowship in Anesthesia Research and Medicine (FARM) program and our two NIH supported T32 training grants.

Research Programs

Basic Science

Visit our basic science page to learn more about our ongoing research. 

Clinical and Translational Science

Visit our clinical and translational science page to learn more about our ongoing research. 

Data Science

Visit our data science page to learn more about our ongoing research. 

Anesthesia T32 Research fellowship

Visit our research fellowship to learn more about our NIH funded opportunities for residents and postdoctoral fellows. 


News Spotlight

Gaudilliere’s Lab Innovative Machine Learning featured on the Cover of Nature Biotechnology

October, 2024

A new machine learning method from the Gaudilliere Lab is featured on the October cover of Nature Biotechnology. The manuscript, “Discovery of Sparse, Reliable Omic Biomarkers with Stabl,” enhances the clinical translation of omics data. This achievement highlights a remarkable collaboration among leading experts, including Martin Angst and Nima Aghaeepour.

Laura Simons Receives NIH UG3/UH3 Award

September, 2024

Congratulations to Laura Simons for receiving an NIH UG3/UH3 award for her proposal, “Targeted Realtime Assessment of Chronic Pain (TRAC-Pain) in Youth.” This project, conducted with Dr. Aghaeepour and collaborators, aims to leverage AI and wearable devices to develop digital biosignatures for monitoring chronic musculoskeletal pain in youth. By collecting continuous physiological data and pain reports, this research seeks to improve therapeutic outcomes and pain management strategies.

Dr. Sun Receives NIH Award for ADRD Research

September 2024

Eric Sun, Assistant Professor, receives an NIH R01 award for his project, “Usage of Novel Linked Databases to Improve the Perioperative Management of Patients With Alzheimer Disease and Related Dementias.” This study aims to analyze postoperative outcomes for patients with ADRD undergoing surgery, ultimately developing individualized risk assessment models and evidence-based guidelines to enhance clinical decision-making and health outcomes.

Congratulations Dr. Sun!

Dr. Bateman Receives R01 Renewal

September, 2024

We are thrilled to announce that Dr. Bateman, in collaboration with Dr. Krista Huybrechts from Harvard, has secured a five-year renewal for their R01 project titled “The Comparative Effectiveness and Safety of Pharmacotherapies for the Treatment of Opioid Use Disorder in Pregnancy.” This important research will leverage advanced epidemiological methods to assess treatment options for opioid use disorder during pregnancy, aiming to improve outcomes for mothers and their babies. 

Congratulations, Dr. Bateman!

Celebrating Innovation: Dr. Aghaeepour Secures NIH Grant

September 2024

Congratulations to Dr. Aghaeepour on being awarded an NIH R41/R42 grant! This funding will support innovative work on utilizing AI to optimize total parenteral nutrition (TPN) in neonatal ICUs. The R41 phase focuses on developing the AI model, while the R42 phase will enable a randomized controlled trial to validate the technology. Receiving both grants as part of a fast-track project is a rare and impressive achievement.

Well done, Dr. Aghaeepour!

Maya Goldesberg Recognized at Stanford Bio-X Symposium

September, 2024

We are excited to announce that Maya Goldesberg, an undergraduate summer student in the Gross Lab, has been recognized at the Stanford Bio-X Interdisciplinary Initiatives Seed Grants Program Symposium. Her poster, titled "Novel Aldehyde Dehydrogenase 2 Variants in Africans/African Americans Affect Acetaldehyde Metabolism," was selected as one of the top 30 among 272 submissions for its impact and innovation.

Congratulations Maya!